Inventor · disambiguated record
James Lillie
Also filed as: LILLIE JAMES · LILLIE JAMES W
10 granted patents·19 pending applications·345 citations·filing 1990–2022
92Inventor score
Files withMILLENNIUM PHARM INC8GENZYME CORP5ANADYS PHARMACEUTICALS INC3MAPLIGHT THERAPEUTICS INC3AMIRA INC2
Top patents by PatentIndex Score
29 records- 0192US7705120B2Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancerMILLENNIUM PHARM INC·Filed 2002·Granted Apr 27, 2010·106 cites·24 claims
- 0290US9139580B2Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2013·Granted Sep 22, 2015·14 cites·1 claims
- 0388US6569628B2Screen employing fluorescence anisotropy to identify compounds with affinity for nucleic acidsANADYS PHARMACEUTICALS INC·Filed 2001·Granted May 27, 2003·16 cites·9 claims
- 0487US9126993B2Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2014·Granted Sep 8, 2015·9 cites·1 claims
- 0584US5324731AMethod of inhibiting transformation of cells in which purine metabolic enzyme activity is elevatedAMIRA INC·Filed 1990·Granted Jun 28, 1994·77 cites·17 claims
- 0680US6331392B1Screen employing fluorescence anisotropy to identify compounds with affinity for nucleic acidsANADYS PHARMACEUTICALS INC·Filed 1998·Granted Dec 18, 2001·29 cites·9 claims
- 0779US6503721B2Screen for compounds with affinity for nucleic acidsANADYS PHARMACEUTICALS INC·Filed 2001·Granted Jan 7, 2003·12 cites·9 claims
- 0877US5321030ACreatine analogs having antiviral activityAMIRA INC·Filed 1991·Granted Jun 14, 1994·64 cites·83 claims
- 0972US2021261557A1Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2021·Application pending·0 cites
- 1071US2010105051A1Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancerMILLENNIUM PHARM INC·Filed 2009·Application pending·0 cites
- 1165US2008311573A1Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancerMILLENNIUM PHARM INC·Filed 2007·Application pending·0 cites
- 1264US2020048266A1Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2019·Application pending·0 cites
- 1361US2003152992A1Screen employing fluorescence anisotropy to identify compounds with affinity for nucleic acidsFiled 2003·Application pending·0 cites
- 1460US2025032460A1Methods of treating neurological disordersMAPLIGHT THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1559US2024189240A1Pharmaceutical compositions comprising zolmitriptanMAPLIGHT THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1659US2003113779A1Screen for compounds with affinity for nucleic acidsFiled 2002·Application pending·0 cites
- 1758US2011092388A1Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancerMILLENNIUM PHARM INC·Filed 2010·Application pending·0 cites
- 1853US2022387396A1Methods of treating the symptoms of autism spectrum disorderMAPLIGHT THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1953US2016207933A1Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2015·Application pending·0 cites
- 2049US6051373AMethods for screening for inhibitors of the transcription-enhancing activity of the X protein of hepatitis B virusSCRIPTGEN PHARM INC·Filed 1994·Granted Apr 18, 2000·13 cites·10 claims
- 2146US2003003479A1Compositions, kits, and methods for identification, assessment, prevention, and therapy of ovarian cancerMILLENNIUM PHARM INC·Filed 2002·Application pending·0 cites
- 2245US6337183B1Screen for compounds with affinity for nucleic acidsSCRIPTGEN PHARM INC·Filed 1996·Granted Jan 8, 2002·5 cites·19 claims
- 2341US2002182619A1Compositions, kits, and methods for identification, assessment, prevention, and therapy of ovarian cancerMILLENNIUM PHARM INC·Filed 2001·Application pending·0 cites
- 2439US2002015956A1Compositions and methods for the identification, assessment, prevention, and therapy of human cancersFiled 2001·Application pending·0 cites
- 2538US2003215805A1Novel genes, compositions, kits, and methods for identification, assessment prevention, and therapy of breast cancerMILLENNIUM PHARM INC·Filed 2002·Application pending·0 cites
- 2637US2003099974A1Novel genes, compositions, kits and methods for identification, assessment, prevention, and therapy of breast cancerMILLENNIUM PHARM INC·Filed 2002·Application pending·0 cites
- 2737US2002110815A1Novel genes, compositions and methods for the identification, assessment, prevention, and therapy of human cancersFiled 2001·Application pending·0 cites
- 2836US2003165831A1Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of ovarian cancerFiled 2001·Application pending·0 cites
- 2931US2002081596A1Compositions and methods for the identification, assessment, prevention, and therapy of human cancersFiled 2001·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →